Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN – Business Wire
Cosette Pharmaceuticals Expands Branded Portfolio through buyout of SYMPAZAN Business Wire Source: news.google.com
Pharma and Biotech
Pharma and Biotech
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders – PR Newswire
Lilly to buy Centessa Pharmaceuticals to advance treatments for sleep-wake disorders PR Newswire Source: news.google.com
Pharma and Biotech
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right – Business Wire
Aurinia Pharmaceuticals to buy Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Business Wire Source: news.google.com
Pharma and Biotech
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) – Business Wire
Merck to buy Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Business Wire Source: news.google.com
Pharma and Biotech
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports – Reuters
Merck nears $6 billion buyout of Terns Pharma to boost cancer portfolio, FT reports Reuters Source: news.google.com
Pharma and Biotech
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery – Business Wire
Apimeds Pharmaceuticals US Inc. Announces Material Breach of combination pact by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery Business Wire Source: news.google.com
Pharma and Biotech
Gilead nears up to $2 billion buyout of biotech Ouro Medicines, FT reports – Reuters
Gilead nears up to $2 billion buyout of biotech Ouro Medicines, FT reports Reuters Source: news.google.com
Pharma and Biotech
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio – PR Newswire
Servier and Day One Biopharmaceuticals announce buyout to expand Servier's rare oncology portfolio PR Newswire Source: news.google.com
Pharma and Biotech
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio – GlobeNewswire
Servier and Day One Biopharmaceuticals announce buyout to expand Servier’s rare oncology portfolio GlobeNewswire Source: news.google.com
Pharma and Biotech
VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp. – GlobeNewswire
VERAXA Biotech Shareholders Approve combination and Issuance of New Shares to Voyager buyout Corp. GlobeNewswire Source: news.google.com